Apogee Therapeutics, Inc. (APGE)
85.75
+3.03
(+3.66%)
USD |
NASDAQ |
Jun 11, 13:22
Apogee Therapeutics EPS Diluted (Quarterly) : -1.064 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.064 |
| December 31, 2025 | -1.026 |
| September 30, 2025 | -1.106 |
| June 30, 2025 | -1.131 |
| March 31, 2025 | -0.9509 |
| December 31, 2024 | -1.130 |
| September 30, 2024 | -0.8631 |
| June 30, 2024 | -0.5984 |
| March 31, 2024 | -0.6394 |
| Date | Value |
|---|---|
| December 31, 2023 | -0.6265 |
| September 30, 2023 | -0.4112 |
| June 30, 2023 | -0.3727 |
| March 31, 2023 | -0.2472 |
| December 31, 2022 | -0.2764 |
| September 30, 2022 | -0.3879 |
| June 30, 2022 | -0.0358 |
| March 31, 2022 | -0.085 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Evommune, Inc. | -0.6437 |
| Cogent Biosciences, Inc. | -0.60 |
| Kymera Therapeutics, Inc. | -0.7098 |
| Erasca, Inc. | -0.6028 |
| GRAIL, Inc. | -2.293 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.11M |
| Total Expenses (Quarterly) | 74.11M |
| Enterprise Value | 5.142B |
| Earnings Yield | -5.05% |
| Normalized Earnings Yield | -5.047 |